This trial will determine if it is safe to forgo surgery after chemoradiotherapy for low rectal cancer if the cancer responds well to the treatment.
2 Primary · 5 Secondary · Reporting Duration: 2 years
Experimental Treatment
90 Total Participants · 1 Treatment Group
Primary Treatment: Non-operative management · No Placebo Group · N/A
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: